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Dr Richard Cambria (Boston, Mass). I would like to open
with one question about the follow-up on the issue of restenosis.
You expressed your data in actuarial methods. Can you tell us how
many patients actually completed the 5-years of follow-up in terms
of assessing the risk of restenosis?
Dr de Donato. We have a mean follow-up of 3 years, but
patientswhohave completed the 5-year follow-up are about 550.The
number of patients at risk were shown under each curve onmy slides.
Dr Wesley Moore (Los Angeles, Calif). I was following your
presentation until you got to the point where you compared the
results of carotid artery stenting with the surgical results from
NASCET and ACAS. Remember that those surgical results are
now 15 to 20-years-old. It is very clear from a number of presen-
tations here and from current publications that the results of
carotid endarterectomy have improved over time. Therefore, it is
unreasonable to compare the results of a contemporary angioplastyfar better if you looked at the current national discharge data study
that has shown contemporary results of carotid endarterectomy.
Mortality and stroke morbidity have dropped with carotid endar-
terectomy over time. If you were to use current carotid endarter-
ectomy data, you would find that the current results of stent/
angioplasty come in second best.
Dr de Donato. Yes, I totally agree with you. But I think that up
to now the old randomized control trials have been of value as a
benchmark to be compared to, whilewe are still waiting for long-term
results from randomized controlled trials comparing carotid artery
stenting and carotid endarterectomy. The aimof this presentationwas
to show that long-term results of CAS are comparable to CEA.
Dr John Ricotta (Stony Brook, NY). The previous paper
showed excellent results in a very broad study that involved multiple
centers and multiple surgeons. You have tremendous results from
three centers, each of which performed at least an average of 1000
carotid stents. How are we going to deal with the issue of volume-
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stent? Andwhat’s going to happen when this methodology is dissem-
inated widely? Do you think it should be disseminated widely, or do
you think it should be done only in very selected centers?
Dr de Donato. Yes, this is true. We think that the learning
curve is very important. We think that the volume experience is
another key factor for successful results. Actually, there were four
centers. But anyway, all four centers are classified in our opinion as
high-volume centers, that means at least they treat more than 100
or 150 CAS procedures every year. So we think that the volume
and patient selection are important to reach the right result.
Dr Jacob Schneiderman (Ramat Gan, Israel). Beyond your
impressive long-term results, aren’t you concerned about the
potential of premature dementia in patients undergoing CAS,
taking into consideration the numerous published data regarding
subclinical cerebral ischemic events, as demonstrated by diffusion
weighted MRI after CAS?
Dr de Donato. I think that we don’t have this data about
dementia. And we have only data about disabling or non-disabling
stroke. We don’t have this data, I’m sorry.Dr Christos Liapis (Athens, Greece). Was neurological ex-
amination part of the protocol for all patients or was a neurologist
called after a neurological event?
Dr deDonato.No, absolutely. To be honest, our patients had
an independent neurologist follow-up only in case of symptoms.
During the normal follow-up, it was the physician that performed
the ultrasound scan who also performed the neurological exami-
nation.
DrAmyReed (Cincinnati, Ohio). I just had a question on the
follow-up. Do you have any information on how long clopidogrel,
or Plavix, was used postprocedure in these patients?
Dr de Donato. Actually, this is a difficult point to explain,
because we have different local reimbursement policies. So for
example, in Italy, the patients have to pay for this drug. Our
medical protocol involves double antiplatelet therapy for at least 1
month after the procedure, and then only one anti-aggregation
drug with either aspirin, ticlopidine, or clopidogrel. But I think
that only about 25% of our patients received Plavix for a long
period of time.
